![KCAS-blog-thumb_2024-07_The Role Dose Form Plays](https://kcasbio.com/wp-content/uploads/2024/08/KCAS-blog-thumb_2024-07_The-Role-Dose-Form-Plays-1-900x900-c-default.webp)
Preclinical formulation analysis supports toxicity studies before and after the investigational new drug application (IND). Multiple analytical studies support drug development progression beyond the IND stage. KCAS Bio performs analytical studies for a variety of clients. How Does KCAS Bio Perform Preclinical Formulation Analysis? KCAS Bio has completed numerous studies…
![KCAS-blog-thumb_2024-00_The Age of Cell _ Gene](https://kcasbio.com/wp-content/uploads/2024/08/KCAS-blog-thumb_2024-00_The-Age-of-Cell-_-Gene-900x900-c-default.webp)
Cell and Gene Therapies (CGTs) are types of treatment that uses cellular or genetic material with the goal of treating a disease or a disordered. Often it can be a combination of cell and gene therapies, which is the case for Chimeric antigen receptor T cells (CAR T-Cells). There are…
![KCAS-blog-thumb_2024-07_Evolution of a CRO](https://kcasbio.com/wp-content/uploads/2024/08/KCAS-blog-thumb_2024-07_Evolution-of-a-CRO-900x900-c-default.webp)
In today’s drug development efforts, Research and Development has increasingly expanded to include multi-country strategies. Over time, pharmaceutical and biotech companies have made substantial impact on economies where development work is conducted, and some countries have developed strategies (i.e. Australia) to attract this lucrative market via financial incentives and offering…
![KCAS-blog-thumb_2024-07_AllMixedUp](https://kcasbio.com/wp-content/uploads/2024/07/KCAS-blog-thumb_2024-07_AllMixedUp-900x900-c-default.webp)
Spectral flow cytometry and the growing array of commercially available fluorophores have led to the development of increasingly complex immunophenotyping panels. Generating robust data depends not only on a strong panel design but also on the use of appropriate reference controls and a solid understanding of spectral unmixing principles. …
![KCAS-blog-thumb_2024-07_What is a CRO_1](https://kcasbio.com/wp-content/uploads/2024/07/KCAS-blog-thumb_2024-07_What-is-a-CRO_1-900x900-c-default.webp)
The world of medicine relies heavily on innovation, and Contract Research Organizations (CROs) are key players behind the scenes. But what exactly is a CRO, and why are these organizations so crucial to the development of new therapies and medical advancements? Let’s explore what CROs do and why they’re vital…
![KCAS-blog-thumb_2024-06_Functional Neutrophil](https://kcasbio.com/wp-content/uploads/2024/07/KCAS-blog-thumb_2024-06_Functional-Neutrophil-900x900-c-default.webp)
The Rise of Immune Cell Therapies and the Importance of Cell Profiling by Flow Cytometry Immunotherapy is revolutionizing patient care, both in traditional oncology applications as well as in autoimmune indications. The complex mechanism of action based on the enhancement or targeted suppression of immune responses is fraught with challenges;…
![KCAS-blog-thumb_2024-06c_podcasts](https://kcasbio.com/wp-content/uploads/2024/06/KCAS-blog-thumb_2024-06c_podcasts-900x900-c-default.webp)
2020 was an odd year for everyone. In what felt like just days, it seemed everything had changed and the rules were being rewritten almost daily about how we would all be engaging with one another. We went from racking up travel, hotel stays and airmiles while visiting our customers…
![KCAS-blog-thumb_2024-06_Dawn-AIS](https://kcasbio.com/wp-content/uploads/2024/06/KCAS-blog-thumb_2024-06_Dawn-AIS-900x900-c-default.webp)
The age of therapeutic conjugation is upon us! Bioanalysis for support of next generation Antibody Drug Conjugates (ADCs) and Antibody siRNA Conjugates (ARCs) have exploded recently due to the efficacy and safety that these therapies offer for immuno-oncology, rare diseases, vaccines and potentially many other diseases. Recently, we have seen…
![WhosTheScientist_K-M_TN](https://kcasbio.com/wp-content/uploads/2024/06/WhosTheScientist_K-M_TN-900x900-c-default.webp)
Georges Köhler and César Milstein: The birth of monoclonal antibodies They discovered the technique for monoclonal antibody production. They won the Nobel Prize in Physiology or Medicine in 1984. They directly led to the development of antibody-based therapies for a vast array of health conditions. Since their initial invention…
![KCAS-blog-thumb_2024-05_Biopharma-LBA-Generic-PK-Assays](https://kcasbio.com/wp-content/uploads/2024/06/KCAS-blog-thumb_2024-05_Biopharma-LBA-Generic-PK-Assays-900x900-c-default.webp)
A pharmacokinetic (PK) assays evaluate how the body affects a specific substance after administration which includes: absorption, biodistribution, metabolism, and excretion. Preclinical (or non-clinical) PK assays play a crucial role in drug development and typically focus on assessing drug safety and maximum tolerable dose. For the development of pre-clinical PK…
![KCAS-blog-thumb_2024-05_Lyon-ALS](https://kcasbio.com/wp-content/uploads/2024/05/KCAS-blog-thumb_2024-05_Lyon-ALS-900x900-c-default.webp)
Charcot, Gehrig, Hawking: A Journey Through ALS When you hear the names Charcot, Gehrig, and Hawking, what comes to mind? These names are all linked by a shared thread: Amyotrophic Lateral Sclerosis, or ALS. ALS, also known as Charcot disease, is named after Jean-Martin Charcot, a neurologist from the Pitié-Salpêtrière…
![KCAS-blog-thumb_2024-04_Neutralizing Antibody Assay 2](https://kcasbio.com/wp-content/uploads/2024/05/KCAS-blog-thumb_2024-04_Neutralizing-Antibody-Assay-2-900x900-c-default.webp)
Neutralizing antibodies (NAbs) are a subset of Anti-drug antibodies (ADAs) that play an important role in understanding the efficacy and safety of a drug product. While most drugs are associated with low risk and do not require a validated NAb assay prior to testing Phase 3 samples, drugs associated with…